MicroRNAs for the Prediction of Early Response to Sorafenib Treatment in Human Hepatocellular Carcinoma

Por Nishida, Naoshi, Arizumi, Tadaaki, Hagiwara, Satoru, Ida, Hiroshi, Sakurai, Toshiharu, Kudo, Masatoshi
Publicado no Liver Cancer (2017)

Cold-inducible RNA-binding protein promotes the development of liver cancer

Por Sakurai, Toshiharu, Yada, Norihisa, Watanabe, Tomohiro, Arizumi, Tadaaki, Hagiwara, Satoru, Ueshima, Kazuomi, Nishida, Naoshi, Fujita, Jun, Kudo, Masatoshi
Publicado no Cancer Sci (2015)

Gankyrin induces STAT3 activation in tumor microenvironment and sorafenib resistance in hepatocellular carcinoma

Por Sakurai, Toshiharu, Yada, Norihisa, Hagiwara, Satoru, Arizumi, Tadaaki, Minaga, Kosuke, Kamata, Ken, Takenaka, Mamoru, Minami, Yasunori, Watanabe, Tomohiro, Nishida, Naoshi, Kudo, Masatoshi
Publicado no Cancer Sci (2017)

Prognostic sub-classification of intermediate-stage hepatocellular carcinoma: a multicenter cohort study with propensity score analysis

Por Ramaswami, Ramya, Pinato, David J., Kubota, Keiichi, Ishizuka, Mitsuru, Arizumi, Tadaaki, Kudo, Masatoshi, Jang, Jeong Won, Kim, Young Woon, Pirisi, Mario, Allara, Elias, Sharma, Rohini
Publicado no Med Oncol (2016)

Comparison of systems for assessment of post-therapeutic response to sorafenib for hepatocellular carcinoma

Por Arizumi, Tadaaki, Ueshima, Kazuomi, Takeda, Haruhiko, Osaki, Yukio, Takita, Masahiro, Inoue, Tatsuo, Kitai, Satoshi, Yada, Norihisa, Hagiwara, Satoru, Minami, Yasunori, Sakurai, Toshiharu, Nishida, Naoshi, Kudo, Masatoshi
Publicado no J Gastroenterol (2014)

Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma

Por Arizumi, Tadaaki, Ueshima, Kazuomi, Minami, Tomohiro, Kono, Masashi, Chishina, Hirokazu, Takita, Masahiro, Kitai, Satoshi, Inoue, Tatsuo, Yada, Norihisa, Hagiwara, Satoru, Minami, Yasunori, Sakurai, Toshiharu, Nishida, Naoshi, Kudo, Masatoshi
Publicado no Liver Cancer (2015)

Unique Association between Global DNA Hypomethylation and Chromosomal Alterations in Human Hepatocellular Carcinoma

Por Nishida, Naoshi, Kudo, Masatoshi, Nishimura, Takafumi, Arizumi, Tadaaki, Takita, Masahiro, Kitai, Satoshi, Yada, Norihisa, Hagiwara, Satoru, Inoue, Tatsuo, Minami, Yasunori, Ueshima, Kazuomi, Sakurai, Toshiharu, Yokomichi, Naosuke, Nagasaka, Takeshi, Goel, Ajay
Publicado em 2013

Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: a multi-center comparative...

Por Pinato, David J., Arizumi, Tadaaki, Jang, Jeong Won, Allara, Elias, Suppiah, Puvan I., Smirne, Carlo, Tait, Paul, Pai, Madhava, Grossi, Glenda, Kim, Young Woon, Pirisi, Mario, Kudo, Masatoshi, Sharma, Rohini
Publicado no Oncotarget (2016)

Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib

Por Howell, Jessica A., Pinato, David J., Ramaswami, Ramya, Arizumi, Tadaaki, Ferrari, Carlotta, Gibbin, Antonello, Burlone, Michela E., Guaschino, Giulia, Toniutto, Pierluigi, Black, James, Sellers, Laura, Kudo, Masatoshi, Pirisi, Mario, Sharma, Rohini
Publicado no Oncotarget (2017)

The Overall Survival of Patients with Hepatocellular Carcinoma Correlates with the Newly Defined Time to Progression after Transarterial Chemoembolization

Por Arizumi, Tadaaki, Ueshima, Kazuomi, Iwanishi, Mina, Minami, Tomohiro, Chishina, Hirokazu, Kono, Masashi, Takita, Masahiro, Yada, Norihisa, Hagiwara, Satoru, Minami, Yasunori, Ida, Hiroshi, Komeda, Yoriaki, Takenaka, Mamoru, Sakurai, Toshiharu, Watanabe, Tomohiro, Nishida, Naoshi, Kudo, Masatoshi
Publicado no Liver Cancer (2017)